Table 1 Characteristics of healthy controls (HC) and patients with systemic lupus erythematosus (SLE)
HC | SLE | |
|---|---|---|
Number | 45 | 71 |
Female/male, n | 41/4 | 66/5 |
Age, years | 36.0 (21.0–56.0) | 36.0 (22.0–60.0) |
Disease duration, years | 7.0 (0.0–31.0) | |
Anti-DNA antibody (IU/mL) | 3.5 (2.0–300.0) | |
C3 (mg/dL) | 67.0 (9.0–195.0) | |
CH50 (U/mL) | 29.4 (2.0–78.1) | |
SLEDAI score | 4.0 (2.0–34.4) | |
SLEDAI < 5, n | 41 | |
SLEDAI ≥ 5, n | 30 | |
Disease | ||
Glomerulonephritis, n | 37 | |
Arthritis, n | 11 | |
Neuropsychiatric SLE, n | 8 | |
Pancytopenia, n | 6 | |
Lupus enteritis, n | 5 | |
Cutaneous lupus erythematosus, n | 3 | |
Pneumonitis, n | 1 | |
Medications | ||
Medication naïve, n | 10 | |
Prednisone, n | 57 | |
Prednisone dose (mg/day) | 7.0 (2.0–45.0) | |
Immunosuppressive agenta, n | 19 | |